Essilorluxottica ADR ESLOY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Ray-Ban Maker EssilorLuxottica's Sales Growth Slows Despite Smartglasses Boom — 2nd Update
-
Ray-Ban Maker EssilorLuxottica's Sales Growth Slows Despite Smartglasses Boom — Update
-
Ray-Ban Maker EssilorLuxottica's Sales Growth Slows Despite Smartglasses Boom
-
Meta Launches New Line of AI Smartglasses
-
EssilorLuxottica Shares Fall as Investors Weigh Impact of Smartglasses
-
EssilorLuxottica Books Continued Sales Growth as AI Glasses Keep Momentum
-
EssilorLuxottica, Meta Launch Prescription AI-Glasses
-
Meta's Smart Glasses Withheld From EU, Bloomberg Says, Citing Source
Trading Information
- Previous Close Price
- $94.40
- Day Range
- $93.67–94.79
- 52-Week Range
- $91.44–186.81
- Bid/Ask
- $80.04 / $94.18
- Shares Outstanding
- 919.18M
- Market Cap
- $86.39B
- Volume/Avg
- 77,454 / 125,934
Key Statistics
- Price/Earnings (Normalized)
- 25.72
- Price/Sales
- 2.57
- Dividend Yield (Trailing)
- 2.46%
- Dividend Yield (Forward)
- 2.46%
- Total Yield
- 3.64%
Company Profile
EssilorLuxottica is a combination of the leading manufacturer of premium frames and sunglasses and the leading manufacturer of optical lenses. Both companies are significantly larger than the next biggest competitor and command over 15% of the fragmented global eyewear market. The company has a broad geographical presence, with around 37% of sales in Europe, 45% in North America, and the rest in Asia and Latin America.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Large Core
- Total Number of Employees
- 213,909
- Website
- https://www.essilorluxottica.com
Competitors
Valuation
|
Metric
|
ESLOY
|
COO
|
|---|---|---|
Price/Earnings (Normalized) | 25.72 | 16.70 |
Price/Book Value | 1.93 | 1.80 |
Price/Sales | 2.57 | 3.56 |
Price/Cash Flow | 12.50 | 15.99 |
Price/Earnings
ESLOY
COO
Financial Strength
|
Metric
|
ESLOY
|
COO
|
|---|---|---|
Quick Ratio | 0.50 | 0.53 |
Current Ratio | 0.89 | 1.27 |
Interest Coverage | 10.54 | 5.43 |
Quick Ratio
ESLOY
COO
Profitability
|
Metric
|
ESLOY
|
COO
|
|---|---|---|
Return on Assets (Normalized) | 5.15% | 7.27% |
Return on Equity (Normalized) | 8.49% | 10.88% |
Return on Invested Capital (Normalized) | 6.46% | 9.04% |
Return on Assets
ESLOY
COO
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|RS^BB##b | LOCK|bC | $139B | |||
| Becton Dickinson & Co
BDX
| LOCK|S! | LOCK|?m&! | $50B | |||
| Alcon Inc
ALC
| LOCK|tg@b&#H | LOCK|c%ML& | $36B | |||
| ResMed Inc
RMD
| LOCK|p><tnBV | LOCK|>sB<! | $32B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|<bzl>$ | LOCK|c@%# | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|SRxVhbTG | LOCK|Rs! | $25B | |||
| Solventum Corp
SOLV
| LOCK|XGP##Mz | LOCK|Yqp | $15B | |||
| The Cooper Companies Inc
COO
| LOCK|C@$bkX! | LOCK|&<Knj | $15B | |||
| Baxter International Inc
BAX
| LOCK|#? | LOCK|%QTKR | $14B | |||
| Align Technology Inc
ALGN
| LOCK|ZYTzYQ | LOCK|$$$j | $13B |
United States